Outlook Therapeutics, Inc. (OTLK)
0.2281
-0.01
(-2.19%)
USD |
NASDAQ |
May 15, 16:00
0.2259
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics EPS Diluted (Quarterly) : -0.0544 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.173 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.453M |
| Revenue (Quarterly) | 0.1274M |
| Total Expenses (Quarterly) | 4.580M |
| Enterprise Value | 38.39M |
| Gross Profit Margin (Quarterly) | -41.05% |
| Profit Margin (Quarterly) | -3.50K% |
| Earnings Yield | -1.09K% |
| Normalized Earnings Yield | -703.59 |